ES2045153T3 - Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos. - Google Patents

Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos.

Info

Publication number
ES2045153T3
ES2045153T3 ES88312128T ES88312128T ES2045153T3 ES 2045153 T3 ES2045153 T3 ES 2045153T3 ES 88312128 T ES88312128 T ES 88312128T ES 88312128 T ES88312128 T ES 88312128T ES 2045153 T3 ES2045153 T3 ES 2045153T3
Authority
ES
Spain
Prior art keywords
methyl cellulose
propil
carboxylates
drugs
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88312128T
Other languages
English (en)
Inventor
Norman G Gaylord
Ashok Nigalaye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forest Laboratories LLC
Original Assignee
Forest Laboratories LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories LLC filed Critical Forest Laboratories LLC
Application granted granted Critical
Publication of ES2045153T3 publication Critical patent/ES2045153T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA FORMA DE DOSIFICACION DE UNIDADES SOLIDAS TERAPEUTICAMENTE ACTIVOS TIENEN UN TRANSPORTADOR MATERIAL COMBINADO CON UN MEDICAMENTO ACTIVO TERAPEUTICAMENTE Y MODELADO Y COMPRIMIDO A UNA FORMA DE UNIDAD SOLIDA DE DOSIFICACION QUE TIENE UN PATRON DE LIBERACION CONTROLADO Y SOSTENIDO SOBRE LA ADMINISTRACION, LA BASE MATERIAL DEL TRANSPORTADOR TIENE UNA MEZCLA DE UNA O MAS ESTERES MONOIONICOS DE CELULOSA Y UN CARBOXILATO ALCALI - METAL, DONDE AL MENOS UNO DE LOS ESTERES DE CELULOSA ES HIDROXIPROPIL METIL CELULOSA QUE TIENE UN NUMERO MEDIO DE PM DE AL MENOS 50000.
ES88312128T 1987-12-21 1988-12-21 Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos. Expired - Lifetime ES2045153T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13566787A 1987-12-21 1987-12-21
US07/284,931 US4983398A (en) 1987-12-21 1988-12-15 Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates

Publications (1)

Publication Number Publication Date
ES2045153T3 true ES2045153T3 (es) 1994-01-16

Family

ID=26833549

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88312128T Expired - Lifetime ES2045153T3 (es) 1987-12-21 1988-12-21 Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos.

Country Status (9)

Country Link
US (1) US4983398A (es)
EP (1) EP0322222B1 (es)
JP (1) JPH0791183B2 (es)
CA (1) CA1331344C (es)
DE (1) DE3867619D1 (es)
DK (1) DK710788A (es)
ES (1) ES2045153T3 (es)
NZ (1) NZ227428A (es)
YU (1) YU46701B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form
US6986898B1 (en) * 1999-06-28 2006-01-17 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils with enzyme inhibitors
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) * 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
JP2005526079A (ja) * 2002-03-15 2005-09-02 サイプレス バイオサイエンス， インコーポレイテッド 内蔵痛症候群を処置するためのｎｅおよび５−ｈｔ再取り込み阻害剤
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (ja) * 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
DK1924246T3 (en) 2005-09-15 2016-01-18 Genzyme Corp PORTION LETTER DEFINITION OF amine polymers
US20080085259A1 (en) * 2006-05-05 2008-04-10 Huval Chad C Amine condensation polymers as phosphate sequestrants
EP2049014A2 (en) * 2006-07-18 2009-04-22 Genzyme Corporation Amine dendrimers
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
EP2114376A1 (en) * 2007-02-23 2009-11-11 Genzyme Corporation Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
US20100166696A1 (en) * 2007-04-27 2010-07-01 Dhal Pradeep K Amido-amine dendrimer compositions
KR100742093B1 (ko) * 2007-05-10 2007-07-24 인하대학교 산학협력단 엔티알유 암호화 및 복호화를 위한 다항식 컨볼루션 연산방법
US20100316589A1 (en) * 2007-12-14 2010-12-16 Hitesh Bhagat Coated Pharmaceutical Compositions
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
BRPI1006902A2 (pt) * 2009-01-23 2016-02-16 Aziende Chimiche Riunte Angelini Francesco A C R A F S P A formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
TWI478733B (zh) * 2009-05-13 2015-04-01 Wyeth Llc 突釋藥物釋放組合物
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament

Also Published As

Publication number Publication date
DE3867619D1 (de) 1992-02-20
NZ227428A (en) 1989-12-21
YU46701B (sh) 1994-04-05
US4983398A (en) 1991-01-08
YU230888A (en) 1990-02-28
JPH02204A (ja) 1990-01-05
CA1331344C (en) 1994-08-09
EP0322222A1 (en) 1989-06-28
DK710788A (da) 1989-06-22
JPH0791183B2 (ja) 1995-10-04
EP0322222B1 (en) 1992-01-08
DK710788D0 (da) 1988-12-20

Similar Documents

Publication Publication Date Title
ES2045153T3 (es) Metodo para la preparacion de formas de dosificacion de farmacos con liberacion sostenida que contienen hidroxi-propil-metilcelulosa y carboxilatos de metales alcalinos.
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
ES2002089T3 (es) Nuevas formulaciones farmaceuticas con liberacion programada que contienen antiflogisticos.
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES2170069T3 (es) 1-alfa-hidroxiprevitamina d para administracion oral.
ES2036457B1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
BE808519A (fr) Medicament pour relachement entretenu d'un ingredient actif et methode d'utilisation de ce medicament
ES2161690T3 (es) Formulaciones farmaceuticas.
ES2090368T3 (es) Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral.
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
HUP0204251A2 (en) Compressed microparticles for dry injection
AR065970A2 (es) Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion
IT8667329A0 (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo
DE69103153D1 (de) Darreichungsform für zeitlich variierende modelle der arzneistofffreisetzung.
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
BE762948A (fr) Appareil distributeur de dose d'un medicament sous la forme d'aerosol
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
PT833618E (pt) Forma farmaceutica solida para utilizacao oral
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
BE847095A (fr) Comprime pour la liberation controlee d'un medicament et sa preparation,
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 322222

Country of ref document: ES